Nektar Therapeutics (NKTR)

Add to Watchlists Create an Alert
11.00 -0.02  -0.18% NASDAQ Jul 23, 5:00PM BATS Real time Currency in USD
View Full Chart
NKTR Price Chart
View All Events

NKTR Events

Date Type Description
02/26/2014 17:00 EDT Misc Nektar Therapeutics, Inc. Q4 2013 Earning Conference Call
02/26/2014 Earnings Nektar Therapeutics, Inc. Q4 2013 Earning Result. Estimate: -0.16.
11/07/2013 17:00 EDT Misc Nektar to Announce Financial Results for the Third Quarter Conference Call
11/07/2013 Earnings Nektar to Announce Financial Results for the Third Quarter Earnings Results. Estimate: -0.24.
10/08/2013 11:30 EDT Misc Nektar Reports on Advancements With Clinical Pipeline and Introduces New Preclinical Candidates at Investor and Analyst R&d Day
09/26/2013 16:30 EDT Misc Nektar Conference Call
08/08/2013 17:00 EDT Misc Second Quarter of 2013 Conference Call
08/08/2013 Earnings Nektar to Announce Financial Results for the Second Quarter of 2013 on Thursday, August 8, 2013, After Close of u.s.-based Financial Markets. Estimate: -0.44.
View All Performance Charts

NKTR Total Returns Comparison

This total returns chart shows the returns to an investor from both price appreciation and dividends (dividends are assumed to be reinvested). Nektar Therapeutics is down 11.22% over the last year vs S&P 500 Total Return up 19.65%, Progenics Pharmaceuticals down 20.26%, and Achillion Pharmaceuticals down 3.36%.

Get Quote for

PDF Report for NKTR

Download Ratings, Key Stats, Performance Charts, Valuations, and Financials in an easy to print format.

Download NKTR Pro Report PDF
Advertisement

Portfolio Strategies Featuring NKTR

Did Nektar Therapeutics make it into our Portfolio Strategies?
Start your YCharts membership now to find out.

NKTR Profile

  • Sector: Healthcare
  • Industry: Biotechnology
  • Company Website: http://www.nektar.com
  • IR Website: http://ir.nektar.com/
  • HQ Country: United States
  • HQ State/Province: California
  • Incorporation Country: United States
  • Incorporation State/Province: Delaware
  • Est. Current Fiscal Quarter End: June 30, 2014
  • Est. Current Fiscal Year End: December 31, 2014
  • Last Fiscal Quarter End: March 31, 2014
  • Last Fiscal Year End: December 31, 2013
  • NAICS: Pharmaceutical Preparation Manufacturing
  • NAICS Code: 325412
  • NAICS Industry: Pharmaceutical and Medicine Manufacturing
  • NAICS Sector: Manufacturing

Nektar Therapeutics, Inc., is a clinical-stage biopharmaceutical company developing a pipeline of drug candidates that utilize its PEGylation and polymer conjugate technology platforms, which are designed to improve the benefits of drugs for patients.

NKTR Excel Add-In Codes

  • Name: =YCI("NKTR","name")
  • Description: =YCI("NKTR","description")
  • Sector: =YCI("NKTR","sector")
  • Industry: =YCI("NKTR","industry")
  • Est. Current Fiscal Year End: =YCI("NKTR","fye")

To find the codes for any of our financial metrics, see our Complete Reference of Metric Codes.

Access our powerful Excel Add-in with a YCharts Professional Membership. Learn More.

Advertisement

Already registered? Click here to sign in.

Access watchlists and custom data alerts.
Start your free account.

required
required
required
required
required
Get Started Now
document.write('');

{{root.upsell.info.feature_headline}}.
Upgrade to {{root.upsell.info.tier_name}}. Start your {{root.upsell.info.tier_name}} Membership

{{root.upsell.info.feature_description}}

{{root.upsell.info.is_upgrade ? "Upgrade Now" : "Start My Free Trial"}}

Already a {{root.upsell.info.tier_name}} Member? Sign in here.